CME Group Inc (CME) Falls 2.55% for December 21

Equities Staff |

One of the S&P 500’s big losers for Monday December 21 was CME Group Inc (CME). The company’s stock fell 2.55% to $92.55 on volume of 3.01 million shares.

The stock opened the day at 94.59 and traded between a low of $92.52 and a high of $94.95. The stock finished the day down $2.42 per share. CME Group Inc has an average daily volume of 1.57 million and a total float of 338.24 million shares. The 50-day SMA for CME Group Inc is $94.43 and its 200-day SMA is $93.56. The high for the stock over the last 52 weeks is $100.87 and the low is $83.43.

CME Group Inc, through its futures exchanges & clearing houses, serves the risk management & investment needs of customers. It offers products like futures & options, foreign exchange, energy, agricultural commodities, weather derivatives & real estate.

CME Group Inc is centered in Chicago, IL, and has 2,680 employees. Today’s trading day leaves the company with a market cap of $31.3 billionwith a P/E Ratio of 24.8. The company has a P/S ratio of 9.75, P/B ratio of 1.46, and a 159.9.

For a complete fundamental analysis analysis of CME Group Inc, check out’s Stock Valuation Analysis report for CME. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The S&P 500 represents the industry standard for large-cap indices. While the Dow Jones Industrial Average (DJIA) may be the most visible stock market index in the country, the S&P 500 has long been relied on by industry insiders and fund managers as the more reliable gauge of portfolio performance.

While the DJIA is price-weighted and only includes 30 stocks, the S&P 500 uses a weighting system that factors in market cap and the size of a company’s free float while including some 500 stocks for a more comprehensive look at the broader markets’ performance. Its performance is far more representative of the large- and mega-cap stocks for any period of time.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

XY Find It

Founded by serial entrepreneur Arie Trouw, XY Findables follows a single guiding principle: customers should never lose anything important again. With over 50,000 users around the world, more than 100,000…